Not yet recruiting
A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
NCT05976568
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Nanjing Tianyinshan Hospital Nanjing, Jiangsu, China
- Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China